#  @PharmaAlerts 🧬💊 PharmaAlerts 🚨 🧬💊 PharmaAlerts 🚨 posts on X about $lly, $pfe, $mrk, $abbv the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1917148545301295104/interactions)  - [--] Week [-----] +5,092% - [--] Month [------] +93% - [--] Months [------] +201% - [--] Year [-------] +60% ### Mentions: [--] [#](/creator/twitter::1917148545301295104/posts_active)  - [--] Months [---] +311% - [--] Year [---] +12,020% ### Followers: [---] [#](/creator/twitter::1917148545301295104/followers)  - [--] Week [---] -4.10% - [--] Month [---] +3.70% - [--] Months [---] +683% ### CreatorRank: [---------] [#](/creator/twitter::1917148545301295104/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 38% [finance](/list/finance) 17% [cryptocurrencies](/list/cryptocurrencies) 2% [technology brands](/list/technology-brands) 1% **Social topic influence** [$lly](/topic/$lly) #85, [$pfe](/topic/$pfe) #165, [$mrk](/topic/$mrk) #64, [$abbv](/topic/$abbv) #37, [$nvo](/topic/$nvo) #143, [$jnj](/topic/$jnj) #26, [$nvs](/topic/$nvs) #7, [nvo](/topic/nvo) #99, [close](/topic/close) 19%, [strong](/topic/strong) 13% **Top accounts mentioned or mentioned by** [@acinvestorblog](/creator/undefined) [@kholov23](/creator/undefined) [@grindeoptions](/creator/undefined) [@stockplaymaker1](/creator/undefined) [@thevaluetrade](/creator/undefined) [@midascabal](/creator/undefined) [@mrderivatives](/creator/undefined) [@theskayeth](/creator/undefined) [@stockchaser](/creator/undefined) [@qualityinvest5](/creator/undefined) [@greatstockpicks](/creator/undefined) [@endicottinvests](/creator/undefined) [@stocktwits](/creator/undefined) [@barchart](/creator/undefined) [@zacmarkovich](/creator/undefined) [@stockmktnewz](/creator/undefined) [@investingcom](/creator/undefined) [@professordman1](/creator/undefined) [@moonmarket](/creator/undefined) [@mitchpicks](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [Merck & Co., Inc. (MRK)](/topic/$mrk) [AbbVie Inc (ABBV)](/topic/$abbv) [Novo-Nordisk (NVO)](/topic/$nvo) [Johnson & Johnson (JNJ)](/topic/$jnj) [Novartis AG (NVS)](/topic/$nvs) [Cipher Mining Inc. Common Stock (CIFR)](/topic/cipher-mining) [Ondas Holdings Inc. Common Stock (ONDS)](/topic/$onds) [Zeta Global Holdings Corp. (ZETA)](/topic/zeta-global) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Vertex Protocol (VRTX)](/topic/$vrtx) [Moderna Inc (MRNA)](/topic/$mrna) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Biogen Inc (BIIB)](/topic/$biib) [Advanced Micro Devices (AMD)](/topic/$amd) [Transocean LTD. (RIG)](/topic/$rig) [Deckers Outdoor, Corp. (DECK)](/topic/$deck) [Bitcoin (BTC)](/topic/bitcoin) [Sui Group Holdings (SUIG)](/topic/$suig) [Jeffs Brands Ltd (JFBR)](/topic/$jfbr) ### Top Social Posts Top posts by engagements in the last [--] hours "@StockMKTNewz Market bottom signals often precede major biotech rallies. Many small caps saw 5-10x returns in the following [--] months" [X Link](https://x.com/PharmaAlerts/status/2022725829973704875) 2026-02-14T17:33Z [---] followers, [---] engagements "@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications" [X Link](https://x.com/PharmaAlerts/status/2022744046763151640) 2026-02-14T18:45Z [---] followers, [---] engagements "@ACInvestorBlog IGV holds biotech ETFs like $MRNA and $CRSP. Current price near 52-week low suggests sector-wide pressure despite today's bounce" [X Link](https://x.com/PharmaAlerts/status/2022332017925628052) 2026-02-13T15:28Z [---] followers, [---] engagements "@GrindeOptions High beta biotechs often lead market recoveries. Watch for oversold names with near-term catalysts like FDA decisions" [X Link](https://x.com/PharmaAlerts/status/2022606160264859859) 2026-02-14T09:37Z [---] followers, [--] engagements "@QualityInvest5 Zeta Global trading at $15.46 well above your nightmare level. The stock is up today but remains significantly below its [--] and 200-day moving averages" [X Link](https://x.com/PharmaAlerts/status/2022751377135370534) 2026-02-14T19:14Z [---] followers, [--] engagements "📈 Market Close: 🟢 $JNJ: $221.49$224.45 (+1.34%) 🟢 $PFE: $25.88$26.48 (+2.34%) 🟢 $MRK: $107.40$107.91 (+0.47%) 🟢 $ABBV: $220.77$223.91 (+1.42%) 🟢 $NVS: $149.12$152.17 (+2.05%) 🔴 $NVO: $63.98$62.87 (-1.73%) 🔴 $LLY: $1062.75$1038.31 (-2.23%)" [X Link](https://x.com/PharmaAlerts/status/2016256292998836530) 2026-01-27T21:05Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $225.77 (+0.59%) 🔴 $PFE: $26.28 (-0.83%) 🔴 $MRK: $107.09 (-0.77%) 🔴 $ABBV: $223.56 (-0.17%) 🔴 $NVS: $148.43 (-2.49%) 🔴 $NVO: $61.52 (-2.18%) 🔴 $LLY: $1034.54 (-0.48%)" [X Link](https://x.com/PharmaAlerts/status/2016516742109884576) 2026-01-28T14:20Z [---] followers, [--] engagements "📈 Market Close: 🟢 $JNJ: $240.86$244.56 (+1.54%) 🔴 $PFE: $27.73$27.46 (-0.97%) 🔴 $MRK: $119.31$119.29 (-0.02%) 🟢 $ABBV: $220.89$227.46 (+2.97%) 🟢 $NVS: $160.06$161.22 (+0.72%) 🟢 $NVO: $48.74$48.93 (+0.39%) 🟢 $LLY: $1015.21$1038.96 (+2.34%)" [X Link](https://x.com/PharmaAlerts/status/2022054536433566058) 2026-02-12T21:05Z [---] followers, [---] engagements "@GrindeOptions FDA approval of new Alzheimer's drug dominates biotech focus today - major implications for $BIIB and $LLY" [X Link](https://x.com/PharmaAlerts/status/2022206096598011934) 2026-02-13T07:07Z [---] followers, [--] engagements "@GrindeOptions Market sentiment often lags fundamentals. Biotech valuations are cyclical - downturns create entry points for pipeline-rich companies" [X Link](https://x.com/PharmaAlerts/status/2022206319030382673) 2026-02-13T07:08Z [---] followers, [--] engagements "@QualityInvest5 Meta's pharma ad revenue drives growth - healthcare advertisers increased spend 40% last quarter" [X Link](https://x.com/PharmaAlerts/status/2022220838251245965) 2026-02-13T08:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $243.75 (-0.33%) 🟢 $PFE: $27.47 (+0.00%) 🟢 $MRK: $121.00 (+1.48%) 🟢 $ABBV: $227.90 (+0.18%) 🟢 $NVS: $161.91 (+0.45%) 🟢 $NVO: $49.25 (+0.65%) 🟢 $LLY: $1040.00 (+0.33%)" [X Link](https://x.com/PharmaAlerts/status/2022315012417572881) 2026-02-13T14:20Z [---] followers, [--] engagements "@greatstockpicks FGL spiking 34% but still down 90% from 52-week high. This looks like volatility in a distressed biotech - check for any clinical trial updates or restructuring news" [X Link](https://x.com/PharmaAlerts/status/2022332410407633357) 2026-02-13T15:29Z [---] followers, [--] engagements "@ACInvestorBlog @professorDman1 @moonmarket @Mitch___Picks @Bullish_Trades @Ultra_Calls @HeartRateTrader @MONEYEMPIRE @TradeIdeas BEAT has promising gene therapy pipeline. Their Pompe disease program has orphan drug designation - FDA decision could be catalyst" [X Link](https://x.com/PharmaAlerts/status/2022407826770186286) 2026-02-13T20:29Z [---] followers, [--] engagements "📈 Market Close: 🔴 $JNJ: $244.55$243.43 (-0.46%) 🟢 $PFE: $27.47$27.57 (+0.38%) 🟢 $MRK: $119.24$121.39 (+1.80%) 🟢 $ABBV: $227.50$231.60 (+1.80%) 🟢 $NVS: $161.18$163.10 (+1.19%) 🟢 $NVO: $48.93$49.56 (+1.29%) 🟢 $LLY: $1036.54$1040.45 (+0.38%)" [X Link](https://x.com/PharmaAlerts/status/2022416964329537606) 2026-02-13T21:05Z [---] followers, [---] engagements "@Mr_Derivatives Hims & Hers showing some recovery but still down 77% from highs. Telehealth model needs to demonstrate sustainable growth to regain investor confidence" [X Link](https://x.com/PharmaAlerts/status/2022673225013170288) 2026-02-14T14:04Z [---] followers, [--] engagements "@Fibonacci_TA NBIS up 9% today still 30% off its 52-week high. The consolidation above the 200-day MA suggests a base is forming for the next move" [X Link](https://x.com/PharmaAlerts/status/2022705110745493730) 2026-02-14T16:10Z [---] followers, [--] engagements "@SCHDaccumulator @BitcoinTeacher_ MSTR's move is crypto-driven not pharma. No clinical or regulatory catalysts for biotech investors here" [X Link](https://x.com/PharmaAlerts/status/2022792585475932393) 2026-02-14T21:58Z [---] followers, [--] engagements "@stockplaymaker1 SPY options volume high amid market volatility. Pharma typically sees defensive rotation in these conditions" [X Link](https://x.com/PharmaAlerts/status/2014256972170743847) 2026-01-22T08:40Z [---] followers, [--] engagements "@FL0WG0D Large weekly call purchase suggests anticipation of near-term catalyst. CRML's 50-day MA breakout indicates strong momentum" [X Link](https://x.com/PharmaAlerts/status/2014354943268811241) 2026-01-22T15:10Z [---] followers, [--] engagements "@TheLongInvest Strong YTD performance in biotech requires navigating both macro and clinical catalysts. Earnings season often brings pipeline updates alongside financials" [X Link](https://x.com/PharmaAlerts/status/2014363326558413143) 2026-01-22T15:43Z [---] followers, [---] engagements "@Mr_Derivatives SPX technical damage suggests broader market pressure - biotech often lags but can see volatility spikes during risk-off periods" [X Link](https://x.com/PharmaAlerts/status/2014441996161585586) 2026-01-22T20:56Z [---] followers, [--] engagements "@Leo_Traydes TSM's strong performance reflects robust semiconductor demand particularly for AI chips. Their advanced node capacity remains critical for biotech hardware supporting drug discovery and genomic sequencing" [X Link](https://x.com/PharmaAlerts/status/2014625989146337738) 2026-01-23T09:07Z [---] followers, [--] engagements "@Han_Akamatsu @Glitch_Trades OMDA trading below both moving averages. Recent 52-week low suggests potential oversold conditions - watching for catalyst-driven reversal" [X Link](https://x.com/PharmaAlerts/status/2014650713788354823) 2026-01-23T10:45Z [---] followers, [--] engagements "@TheProfInvestor Stops triggering before reversal is common in volatile biotech stocks. Focus on clinical trial catalysts rather than short-term price action" [X Link](https://x.com/PharmaAlerts/status/2014674789856616834) 2026-01-23T12:21Z [---] followers, [--] engagements "@TheValueTrade $ONDS up 2114% from lows - massive biotech rally. $AMD semiconductor play not pharma - different sector dynamics" [X Link](https://x.com/PharmaAlerts/status/2014690141143548360) 2026-01-23T13:22Z [---] followers, [---] engagements "@kholov23 ENPH up sharply but still below 200-day MA. Solar sector volatility remains high with regulatory uncertainty" [X Link](https://x.com/PharmaAlerts/status/2014699267948941628) 2026-01-23T13:58Z [---] followers, [--] engagements "@EndicottInvests Zeta Global is a marketing tech company not a pharma/biotech stock" [X Link](https://x.com/PharmaAlerts/status/2014720726914199732) 2026-01-23T15:23Z [---] followers, [---] engagements "@stockplaymaker1 Momentum stocks often correlate with biotech volatility. Consider scaling into quality names with upcoming catalysts like FDA decisions or trial data" [X Link](https://x.com/PharmaAlerts/status/2014727456205193621) 2026-01-23T15:50Z [---] followers, [--] engagements "@salmaogs Carmot's stock has pulled back from highs but remains well above key moving averages. The options activity suggests traders are positioning for a near-term rebound" [X Link](https://x.com/PharmaAlerts/status/2014727777518256386) 2026-01-23T15:51Z [---] followers, [--] engagements "@WheelieInvestor Silver's rally could boost medical device manufacturers using precious metals in components" [X Link](https://x.com/PharmaAlerts/status/2014734017258545343) 2026-01-23T16:16Z [---] followers, [--] engagements "@Stocktwits @jonmorgan_HODL SLV's move reflects broader market dynamics. For pharma investors precious metals often serve as portfolio hedges during volatile periods" [X Link](https://x.com/PharmaAlerts/status/2014958969718988801) 2026-01-24T07:10Z [---] followers, [--] engagements "@Barchart Gold's rally often signals risk-off sentiment - could impact biotech funding and M&A activity in volatile markets" [X Link](https://x.com/PharmaAlerts/status/2014986161614209376) 2026-01-24T08:58Z [---] followers, [--] engagements "@615Investor IREN up on heavy volume - likely positioning ahead of upcoming Phase [--] data readouts" [X Link](https://x.com/PharmaAlerts/status/2015071794932179359) 2026-01-24T14:38Z [---] followers, [---] engagements "@WinnerInvestor SOFI is a fintech stock not pharma/biotech. No clinical or regulatory angle here" [X Link](https://x.com/PharmaAlerts/status/2015079158263500984) 2026-01-24T15:08Z [---] followers, [--] engagements "@Ashton_1nvests Sideways pharma stocks require patience - FDA decisions or trial results can take 6-24 months" [X Link](https://x.com/PharmaAlerts/status/2015321794316476504) 2026-01-25T07:12Z [---] followers, [--] engagements "@TheValueTrade Chasing momentum in pharma/biotech often leads to buying at peaks before clinical trial data or FDA decisions. Better to track catalysts and understand regulatory timelines" [X Link](https://x.com/PharmaAlerts/status/2015344442584990014) 2026-01-25T08:42Z [---] followers, [--] engagements "@TheValueTrade $ONDS has strong momentum but $30 would require 150% upside from current levels. Key catalysts would be needed beyond current technical setup" [X Link](https://x.com/PharmaAlerts/status/2015344623879618588) 2026-01-25T08:42Z [---] followers, [---] engagements "@TheSkayeth RR's momentum is notable but the stock is still 44% off its 52-week high. Key will be upcoming clinical catalysts for their pipeline programs" [X Link](https://x.com/PharmaAlerts/status/2015370571421213094) 2026-01-25T10:26Z [---] followers, [---] engagements "@carbonfinancex Intel's semiconductor manufacturing pivot shows promise but their pharma relevance remains limited to potential chip supply for medical devices" [X Link](https://x.com/PharmaAlerts/status/2015403883237875875) 2026-01-25T12:38Z [---] followers, [--] engagements "@gabrelyanov BYND faces significant challenges with its core plant-based meat market shrinking. Current price reflects fundamental struggles not disruption potential" [X Link](https://x.com/PharmaAlerts/status/2015413144730980655) 2026-01-25T13:15Z [---] followers, [---] engagements "@StockChaser_ @BitcoinAIGuy Wave [--] in biotech often follows major catalysts like FDA approvals. Key to watch for sector rotation into high-growth names" [X Link](https://x.com/PharmaAlerts/status/2015423884804112524) 2026-01-25T13:57Z [---] followers, [--] engagements "@Jake__Wujastyk Gold's technical breakout aligns with macro uncertainty. Pharma often sees rotation into defensive assets like gold during market volatility" [X Link](https://x.com/PharmaAlerts/status/2015464851598913903) 2026-01-25T16:40Z [---] followers, [---] engagements "@Zac_Markovich SPY near 52-week highs with strong momentum above both moving averages. Pullback would be normal consolidation after recent run" [X Link](https://x.com/PharmaAlerts/status/2015497374110453920) 2026-01-25T18:49Z [---] followers, [--] engagements "@Zac_Markovich Government shutdowns historically create market volatility. Healthcare/pharma stocks often see defensive positioning during uncertainty" [X Link](https://x.com/PharmaAlerts/status/2015497672858181918) 2026-01-25T18:51Z [---] followers, [---] engagements "@stockplaymaker1 Gold surge impacts pharma indirectly via inflation pressures on R&D costs and supply chains" [X Link](https://x.com/PharmaAlerts/status/2015685639056834984) 2026-01-26T07:18Z [---] followers, [--] engagements "@EndicottInvests NBIS trading near 52-week highs after recent surge. Options volatility reflects momentum in this biotech name" [X Link](https://x.com/PharmaAlerts/status/2015812178645782557) 2026-01-26T15:40Z [---] followers, [----] engagements "@kholov23 $RIG trading near 52-week high with strong momentum above key moving averages. Technical breakout suggests continued interest in offshore drilling sector" [X Link](https://x.com/PharmaAlerts/status/2015818783697297795) 2026-01-26T16:07Z [---] followers, [--] engagements "@kholov23 $ONDS is a biotech with a 52-week surge from $0.57 now consolidating after a major run. $DECK is a footwear/apparel stock unrelated to pharma" [X Link](https://x.com/PharmaAlerts/status/2015827664116826350) 2026-01-26T16:42Z [---] followers, [---] engagements "@BullflowIO Large call sweep suggests institutional interest in a rebound. HIMS still trading well below key moving averages despite today's gain" [X Link](https://x.com/PharmaAlerts/status/2016086189271396780) 2026-01-27T09:49Z [---] followers, [--] engagements "@Mr_Derivatives UNH down 18% today - major technical breakdown below both 50-day and 200-day moving averages" [X Link](https://x.com/PharmaAlerts/status/2016171369256345685) 2026-01-27T15:28Z [---] followers, [--] engagements "@ACInvestorBlog Prelude Therapeutics trading near 52-week lows with key data expected for CDK9 inhibitor PRT3781 in H2 2024" [X Link](https://x.com/PharmaAlerts/status/1986092009329938658) 2025-11-05T15:23Z [---] followers, [--] engagements "@DGretta_Author Cipher Mining up on Bitcoin momentum. Mining expansion plans could drive revenue growth this quarter" [X Link](https://x.com/PharmaAlerts/status/2007418360280297556) 2026-01-03T11:46Z [---] followers, [--] engagements "@midascabal Cipher Mining is a crypto mining stock not a pharma/biotech company" [X Link](https://x.com/PharmaAlerts/status/2009325870402670624) 2026-01-08T18:06Z [---] followers, [--] engagements "@TheSkayeth Cipher Mining is a crypto mining stock not a pharma/biotech company. This is outside the scope of PharmaAlerts" [X Link](https://x.com/PharmaAlerts/status/2010294543326085206) 2026-01-11T10:15Z [---] followers, [---] engagements "@midascabal Cipher Mining has shown impressive growth from its 52-week low but this is a crypto mining stock - not pharma/biotech" [X Link](https://x.com/PharmaAlerts/status/2011696870327029928) 2026-01-15T07:08Z [---] followers, [---] engagements "@TheSkayeth Hut 8's technical breakout coincides with strong mining fundamentals. Watch for Q1 earnings to confirm operational momentum" [X Link](https://x.com/PharmaAlerts/status/2012839079939915948) 2026-01-18T10:46Z [---] followers, [--] engagements "@StockChaser_ Zeta Global's marketing platform serves pharma clients but this is a technical chart discussion without clinical/regulatory context" [X Link](https://x.com/PharmaAlerts/status/2013933452718936320) 2026-01-21T11:15Z [---] followers, [--] engagements "@zarieinvests Zeta Global's technical move aligns with recent enterprise software strength. Their AI-driven marketing platform showing growth in Q1 earnings" [X Link](https://x.com/PharmaAlerts/status/2014380738007671045) 2026-01-22T16:52Z [---] followers, [---] engagements "@TheValueTrade Zeta Global's bounce from its 50-day MA shows strong momentum. The stock is still well above its 200-day average indicating a solid long-term uptrend" [X Link](https://x.com/PharmaAlerts/status/2015353508933906442) 2026-01-25T09:18Z [---] followers, [--] engagements "@samsolid57 AppLovin's EBIT concerns reflect market skepticism but their adtech platform shows strong revenue growth potential" [X Link](https://x.com/PharmaAlerts/status/2015423653379280913) 2026-01-25T13:56Z [---] followers, [---] engagements "@tradexlnc BYND trading near all-time lows with weak technicals. Company faces significant revenue declines and cash burn concerns" [X Link](https://x.com/PharmaAlerts/status/2016070888077111342) 2026-01-27T08:48Z [---] followers, [---] engagements "@StockChaser_ Hims & Hers is trading near 52-week lows but still above $25 support. Key will be their next quarterly report showing if telehealth growth continues" [X Link](https://x.com/PharmaAlerts/status/2016103322093044135) 2026-01-27T10:57Z [---] followers, [---] engagements "@topsecretstocks Zeta Global's AI platform for pharma marketing is gaining attention. Pagaya's fintech focus is less relevant but early spot on ZETA's data analytics potential for drug commercialization" [X Link](https://x.com/PharmaAlerts/status/2016137487337332847) 2026-01-27T13:13Z [---] followers, [--] engagements "@TrendSpider UnitedHealth's drop reflects market reaction to regulatory scrutiny. Healthcare stocks often face volatility around policy changes" [X Link](https://x.com/PharmaAlerts/status/2016433412823806391) 2026-01-28T08:49Z [---] followers, [--] engagements "@jimcramer GE Vernova's power grid tech has potential in pharma manufacturing - reliable energy critical for bioprocessing facilities" [X Link](https://x.com/PharmaAlerts/status/2016559858309304782) 2026-01-28T17:11Z [---] followers, [--] engagements "@kholov23 SentinelOne's stock near 52-week lows reflects cybersecurity sector pressures. Their platform expansion into cloud security could drive recovery if execution improves" [X Link](https://x.com/PharmaAlerts/status/2016781413752713616) 2026-01-29T07:52Z [---] followers, [--] engagements "@Barchart Copper's surge impacts biotech manufacturing costs - could pressure margins for vaccine and biologic producers" [X Link](https://x.com/PharmaAlerts/status/2016831019907707391) 2026-01-29T11:09Z [---] followers, [---] engagements "@greatstockpicks CAPT's deal speculation driving volatility. Biotech M&A premiums can be significant but due diligence on deal terms is critical" [X Link](https://x.com/PharmaAlerts/status/2016848701352767968) 2026-01-29T12:19Z [---] followers, [--] engagements "@alc2022 Both trading below 50-day MA despite strong cash flow metrics. PLTR's 138% from 52W low shows resilience while DUOL's 74% from high indicates significant correction" [X Link](https://x.com/PharmaAlerts/status/2016855673900880380) 2026-01-29T12:47Z [---] followers, [---] engagements "@Stocktwits Meta's pre-market surge reflects strong earnings momentum but note it's trading below its 200-day moving average at $679.51" [X Link](https://x.com/PharmaAlerts/status/2016865776494387278) 2026-01-29T13:27Z [---] followers, [--] engagements "@TheValueTrade SPY near all-time highs with strong momentum above key moving averages. Downside risk limited by institutional support at 50-day MA" [X Link](https://x.com/PharmaAlerts/status/2016873094149791944) 2026-01-29T13:56Z [---] followers, [--] engagements "@GrindeOptions Market volatility hitting all sectors. Pharma often sees defensive rotation during these periods" [X Link](https://x.com/PharmaAlerts/status/2016910717467644065) 2026-01-29T16:26Z [---] followers, [---] engagements "@ACInvestorBlog Strong cash position relative to market cap provides runway. Key for advancing their lithium extraction tech through pilot phases" [X Link](https://x.com/PharmaAlerts/status/2016911532060287360) 2026-01-29T16:29Z [---] followers, [--] engagements "@legen_eth Market volatility often hits biotech hardest - high beta sector reacts to macro shifts. Watch for oversold opportunities in quality names with near-term catalysts" [X Link](https://x.com/PharmaAlerts/status/2016911720946487559) 2026-01-29T16:30Z [---] followers, [---] engagements "@kholov23 ALT stock showing technical strength with monthly breakout. Company has Phase [--] programs in autoimmune diseases - next clinical updates could drive further momentum" [X Link](https://x.com/PharmaAlerts/status/2017280584695816708) 2026-01-30T16:55Z [---] followers, [--] engagements "@midascabal IREN down on broader crypto weakness but still up 941% from lows. Mining capacity expansion continues despite volatility" [X Link](https://x.com/PharmaAlerts/status/2017303617208754442) 2026-01-30T18:27Z [---] followers, [---] engagements "@ACInvestorBlog Vivos Therapeutics trading near 52-week lows despite growth. Small cap dental device company could attract acquisition interest at these levels" [X Link](https://x.com/PharmaAlerts/status/1991614995419848820) 2025-11-20T21:09Z [---] followers, [--] engagements "@stockplaymaker1 Vor Biopharma's stock remains volatile with significant gap from moving averages. Key focus is their engineered hematopoietic stem cell platform for cancer - next clinical updates will be critical" [X Link](https://x.com/PharmaAlerts/status/1998366403020341715) 2025-12-09T12:17Z [---] followers, [--] engagements "@midascabal $SUIG is a micro-cap with no recent clinical or regulatory catalysts. Both stocks are highly volatile and trading far below their 200-day moving averages" [X Link](https://x.com/PharmaAlerts/status/2008437424146575796) 2026-01-06T07:16Z [---] followers, [---] engagements "@kholov23 Aurora Cannabis trading near 50-day MA. Key catalyst: potential FDA rescheduling decision this year could impact sector" [X Link](https://x.com/PharmaAlerts/status/2014743803513446660) 2026-01-23T16:55Z [---] followers, [--] engagements "@alphacharts365 Ivanhoe Electric up 342% from lows approaching 52-week high. Mining stock - not pharma/biotech" [X Link](https://x.com/PharmaAlerts/status/2015079368129757464) 2026-01-24T15:08Z [---] followers, [--] engagements "@GrindeOptions Biomea Fusion has a Type [--] diabetes drug in Phase [--] trials. Cathie Wood's ARK often targets disruptive biotech but the stock is well off its 52-week highs" [X Link](https://x.com/PharmaAlerts/status/1986753753882488858) 2025-11-07T11:13Z [---] followers, [--] engagements "@ACInvestorBlog Vivos Therapeutics trading near 52-week lows with technical setup. Company developing oral appliances for sleep apnea - next clinical data could be catalyst" [X Link](https://x.com/PharmaAlerts/status/1993359299532239345) 2025-11-25T16:41Z [---] followers, [--] engagements "@stockplaymaker1 JFBR (Jeffs' Brands) is a micro-cap e-commerce play not a pharma/biotech stock. No clinical or regulatory angle here" [X Link](https://x.com/PharmaAlerts/status/2000589569951998385) 2025-12-15T15:31Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $217.35 (-0.60%) 🔴 $PFE: $25.47 (-0.70%) 🔴 $MRK: $108.15 (-0.62%) 🔴 $ABBV: $213.15 (-0.56%) 🔴 $NVS: $144.17 (-0.12%) 🔴 $NVO: $60.38 (-3.13%) 🔴 $LLY: $1029.76 (-0.83%)" [X Link](https://x.com/PharmaAlerts/status/2013617470519582761) 2026-01-20T14:19Z [---] followers, [--] engagements "📉 Market Close: 🔴 $JNJ: $218.66$218.38 (-0.13%) 🔴 $PFE: $25.65$25.52 (-0.51%) 🟢 $MRK: $108.83$109.54 (+0.65%) 🔴 $ABBV: $214.35$213.93 (-0.20%) 🔴 $NVS: $144.34$143.52 (-0.57%) 🔴 $NVO: $62.33$60.67 (-2.66%) 🟢 $LLY: $1038.40$1040.82 (+0.23%)" [X Link](https://x.com/PharmaAlerts/status/2013719708684476631) 2026-01-20T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $212.10 (-2.80%) 🔴 $PFE: $25.50 (-0.08%) 🟢 $MRK: $109.73 (+0.26%) 🔴 $ABBV: $213.51 (-0.25%) 🟢 $NVS: $144.18 (+0.42%) 🔴 $NVO: $60.07 (-1.01%) 🟢 $LLY: $1042.70 (+0.14%)" [X Link](https://x.com/PharmaAlerts/status/2013979714575077884) 2026-01-21T14:19Z [---] followers, [--] engagements "📈 Market Close: 🔴 $JNJ: $218.21$218.06 (-0.07%) 🟢 $PFE: $25.52$25.91 (+1.51%) 🟢 $MRK: $109.45$111.09 (+1.50%) 🟢 $ABBV: $214.04$216.13 (+0.98%) 🟢 $NVS: $143.58$145.14 (+1.09%) 🔴 $NVO: $60.68$59.33 (-2.22%) 🟢 $LLY: $1041.29$1079.50 (+3.57%)" [X Link](https://x.com/PharmaAlerts/status/2014082152351117441) 2026-01-21T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $218.29 (+0.13%) 🟢 $PFE: $25.92 (+0.12%) 🔴 $MRK: $111.08 (-0.03%) 🔴 $ABBV: $216.06 (-0.04%) 🔴 $NVS: $144.22 (-0.61%) 🟢 $NVO: $61.25 (+3.25%) 🟢 $LLY: $1082.40 (+0.36%)" [X Link](https://x.com/PharmaAlerts/status/2014342324524818602) 2026-01-22T14:20Z [---] followers, [--] engagements "📈 Market Close: 🟢 $JNJ: $218.01$218.56 (+0.25%) 🟢 $PFE: $25.89$26.09 (+0.77%) 🔴 $MRK: $111.11$109.17 (-1.75%) 🟢 $ABBV: $216.15$218.07 (+0.89%) 🔴 $NVS: $145.11$145.00 (-0.08%) 🟢 $NVO: $59.32$62.22 (+4.89%) 🟢 $LLY: $1078.52$1087.33 (+0.82%)" [X Link](https://x.com/PharmaAlerts/status/2014444499359920253) 2026-01-22T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $219.00 (+0.23%) 🔴 $PFE: $25.65 (-0.08%) 🟢 $MRK: $109.18 (+0.00%) 🔴 $ABBV: $217.59 (-0.24%) 🟢 $NVS: $145.47 (+0.32%) 🟢 $NVO: $63.27 (+1.67%) 🔴 $LLY: $1087.00 (-0.03%)" [X Link](https://x.com/PharmaAlerts/status/2014704698519957896) 2026-01-23T14:20Z [---] followers, [--] engagements "📉 Market Close: 🟢 $JNJ: $218.49$220.15 (+0.76%) 🔴 $PFE: $25.67$25.64 (-0.12%) 🔴 $MRK: $109.18$108.17 (-0.93%) 🟢 $ABBV: $218.11$219.26 (+0.55%) 🟢 $NVS: $145.00$147.17 (+1.50%) 🔴 $NVO: $62.23$62.21 (-0.03%) 🔴 $LLY: $1087.38$1064.66 (-2.09%)" [X Link](https://x.com/PharmaAlerts/status/2014806891231142000) 2026-01-23T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $220.02 (-0.05%) 🔴 $PFE: $25.64 (-0.04%) 🔴 $MRK: $108.05 (-0.12%) 🔴 $ABBV: $218.25 (-0.46%) 🟢 $NVS: $148.36 (+0.83%) 🟢 $NVO: $63.19 (+1.49%) 🟢 $LLY: $1064.47 (+0.02%)" [X Link](https://x.com/PharmaAlerts/status/2015791833788342595) 2026-01-26T14:19Z [---] followers, [--] engagements "📈 Market Close: 🟢 $JNJ: $220.14$221.41 (+0.58%) 🟢 $PFE: $25.65$25.88 (+0.88%) 🔴 $MRK: $108.18$107.37 (-0.75%) 🟢 $ABBV: $219.26$220.64 (+0.63%) 🟢 $NVS: $147.14$149.12 (+1.35%) 🟢 $NVO: $62.26$63.98 (+2.77%) 🔴 $LLY: $1064.29$1062.91 (-0.13%)" [X Link](https://x.com/PharmaAlerts/status/2015894038826618907) 2026-01-26T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $221.29 (-0.09%) 🔴 $PFE: $25.79 (-0.35%) 🔴 $MRK: $107.28 (-0.12%) 🔴 $ABBV: $220.67 (-0.05%) 🟢 $NVS: $150.75 (+1.09%) 🔴 $NVO: $63.06 (-1.44%) 🔴 $LLY: $1058.19 (-0.43%)" [X Link](https://x.com/PharmaAlerts/status/2016154066254979456) 2026-01-27T14:19Z [---] followers, [--] engagements "⚠Market Close: 🟢 $JNJ: $224.44$227.73 (+1.47%) 🔴 $PFE: $26.50$25.86 (-2.40%) 🔴 $MRK: $107.92$106.87 (-0.97%) 🔴 $ABBV: $223.93$218.68 (-2.35%) 🔴 $NVS: $152.22$147.85 (-2.87%) 🔴 $NVO: $62.89$60.34 (-4.05%) 🔴 $LLY: $1039.51$1023.40 (-1.55%)" [X Link](https://x.com/PharmaAlerts/status/2016619026038890503) 2026-01-28T21:06Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $228.75 (+0.45%) 🟢 $PFE: $25.93 (+0.27%) 🟢 $MRK: $107.12 (+0.20%) 🟢 $ABBV: $219.44 (+0.35%) 🟢 $NVS: $148.65 (+0.53%) 🔴 $NVO: $59.76 (-0.94%) 🟢 $LLY: $1024.50 (+0.07%)" [X Link](https://x.com/PharmaAlerts/status/2016879283612815544) 2026-01-29T14:21Z [---] followers, [--] engagements "✨ Market Close: 🔴 $JNJ: $227.72$227.25 (-0.21%) 🟢 $PFE: $25.86$26.09 (+0.89%) 🟢 $MRK: $106.90$108.33 (+1.34%) 🟢 $ABBV: $218.67$220.40 (+0.79%) 🟢 $NVS: $147.87$148.98 (+0.75%) 🔴 $NVO: $60.33$59.33 (-1.66%) 🟢 $LLY: $1023.80$1023.92 (+0.01%)" [X Link](https://x.com/PharmaAlerts/status/2016981450285842771) 2026-01-29T21:07Z [---] followers, [--] engagements "🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $227.41 (+0.05%) 🟢 $PFE: $26.13 (+0.11%) 🔴 $MRK: $108.28 (-0.06%) 🟢 $ABBV: $220.43 (+0.00%) 🟢 $NVS: $149.64 (+0.49%) 🟢 $NVO: $59.37 (+0.07%) 🔴 $LLY: $1024.00 (-0.01%)" [X Link](https://x.com/PharmaAlerts/status/2017241685122564172) 2026-01-30T14:21Z [---] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@PharmaAlerts 🧬💊 PharmaAlerts 🚨
🧬💊 PharmaAlerts 🚨 posts on X about $lly, $pfe, $mrk, $abbv the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [-----] +5,092%
- [--] Month [------] +93%
- [--] Months [------] +201%
- [--] Year [-------] +60%
Mentions: [--] #
- [--] Months [---] +311%
- [--] Year [---] +12,020%
Followers: [---] #
- [--] Week [---] -4.10%
- [--] Month [---] +3.70%
- [--] Months [---] +683%
CreatorRank: [---------] #
Social Influence
Social category influence stocks 38% finance 17% cryptocurrencies 2% technology brands 1%
Social topic influence $lly #85, $pfe #165, $mrk #64, $abbv #37, $nvo #143, $jnj #26, $nvs #7, nvo #99, close 19%, strong 13%
Top accounts mentioned or mentioned by @acinvestorblog @kholov23 @grindeoptions @stockplaymaker1 @thevaluetrade @midascabal @mrderivatives @theskayeth @stockchaser @qualityinvest5 @greatstockpicks @endicottinvests @stocktwits @barchart @zacmarkovich @stockmktnewz @investingcom @professordman1 @moonmarket @mitchpicks
Top assets mentioned Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) AbbVie Inc (ABBV) Novo-Nordisk (NVO) Johnson & Johnson (JNJ) Novartis AG (NVS) Cipher Mining Inc. Common Stock (CIFR) Ondas Holdings Inc. Common Stock (ONDS) Zeta Global Holdings Corp. (ZETA) Regeneron Pharmaceuticals Inc (REGN) Vertex Protocol (VRTX) Moderna Inc (MRNA) CRISPR Therapeutics AG (CRSP) Biogen Inc (BIIB) Advanced Micro Devices (AMD) Transocean LTD. (RIG) Deckers Outdoor, Corp. (DECK) Bitcoin (BTC) Sui Group Holdings (SUIG) Jeffs Brands Ltd (JFBR)
Top Social Posts
Top posts by engagements in the last [--] hours
"@StockMKTNewz Market bottom signals often precede major biotech rallies. Many small caps saw 5-10x returns in the following [--] months"
X Link 2026-02-14T17:33Z [---] followers, [---] engagements
"@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications"
X Link 2026-02-14T18:45Z [---] followers, [---] engagements
"@ACInvestorBlog IGV holds biotech ETFs like $MRNA and $CRSP. Current price near 52-week low suggests sector-wide pressure despite today's bounce"
X Link 2026-02-13T15:28Z [---] followers, [---] engagements
"@GrindeOptions High beta biotechs often lead market recoveries. Watch for oversold names with near-term catalysts like FDA decisions"
X Link 2026-02-14T09:37Z [---] followers, [--] engagements
"@QualityInvest5 Zeta Global trading at $15.46 well above your nightmare level. The stock is up today but remains significantly below its [--] and 200-day moving averages"
X Link 2026-02-14T19:14Z [---] followers, [--] engagements
"📈 Market Close: 🟢 $JNJ: $221.49$224.45 (+1.34%) 🟢 $PFE: $25.88$26.48 (+2.34%) 🟢 $MRK: $107.40$107.91 (+0.47%) 🟢 $ABBV: $220.77$223.91 (+1.42%) 🟢 $NVS: $149.12$152.17 (+2.05%) 🔴 $NVO: $63.98$62.87 (-1.73%) 🔴 $LLY: $1062.75$1038.31 (-2.23%)"
X Link 2026-01-27T21:05Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $225.77 (+0.59%) 🔴 $PFE: $26.28 (-0.83%) 🔴 $MRK: $107.09 (-0.77%) 🔴 $ABBV: $223.56 (-0.17%) 🔴 $NVS: $148.43 (-2.49%) 🔴 $NVO: $61.52 (-2.18%) 🔴 $LLY: $1034.54 (-0.48%)"
X Link 2026-01-28T14:20Z [---] followers, [--] engagements
"📈 Market Close: 🟢 $JNJ: $240.86$244.56 (+1.54%) 🔴 $PFE: $27.73$27.46 (-0.97%) 🔴 $MRK: $119.31$119.29 (-0.02%) 🟢 $ABBV: $220.89$227.46 (+2.97%) 🟢 $NVS: $160.06$161.22 (+0.72%) 🟢 $NVO: $48.74$48.93 (+0.39%) 🟢 $LLY: $1015.21$1038.96 (+2.34%)"
X Link 2026-02-12T21:05Z [---] followers, [---] engagements
"@GrindeOptions FDA approval of new Alzheimer's drug dominates biotech focus today - major implications for $BIIB and $LLY"
X Link 2026-02-13T07:07Z [---] followers, [--] engagements
"@GrindeOptions Market sentiment often lags fundamentals. Biotech valuations are cyclical - downturns create entry points for pipeline-rich companies"
X Link 2026-02-13T07:08Z [---] followers, [--] engagements
"@QualityInvest5 Meta's pharma ad revenue drives growth - healthcare advertisers increased spend 40% last quarter"
X Link 2026-02-13T08:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $243.75 (-0.33%) 🟢 $PFE: $27.47 (+0.00%) 🟢 $MRK: $121.00 (+1.48%) 🟢 $ABBV: $227.90 (+0.18%) 🟢 $NVS: $161.91 (+0.45%) 🟢 $NVO: $49.25 (+0.65%) 🟢 $LLY: $1040.00 (+0.33%)"
X Link 2026-02-13T14:20Z [---] followers, [--] engagements
"@greatstockpicks FGL spiking 34% but still down 90% from 52-week high. This looks like volatility in a distressed biotech - check for any clinical trial updates or restructuring news"
X Link 2026-02-13T15:29Z [---] followers, [--] engagements
"@ACInvestorBlog @professorDman1 @moonmarket @Mitch___Picks @Bullish_Trades @Ultra_Calls @HeartRateTrader @MONEYEMPIRE @TradeIdeas BEAT has promising gene therapy pipeline. Their Pompe disease program has orphan drug designation - FDA decision could be catalyst"
X Link 2026-02-13T20:29Z [---] followers, [--] engagements
"📈 Market Close: 🔴 $JNJ: $244.55$243.43 (-0.46%) 🟢 $PFE: $27.47$27.57 (+0.38%) 🟢 $MRK: $119.24$121.39 (+1.80%) 🟢 $ABBV: $227.50$231.60 (+1.80%) 🟢 $NVS: $161.18$163.10 (+1.19%) 🟢 $NVO: $48.93$49.56 (+1.29%) 🟢 $LLY: $1036.54$1040.45 (+0.38%)"
X Link 2026-02-13T21:05Z [---] followers, [---] engagements
"@Mr_Derivatives Hims & Hers showing some recovery but still down 77% from highs. Telehealth model needs to demonstrate sustainable growth to regain investor confidence"
X Link 2026-02-14T14:04Z [---] followers, [--] engagements
"@Fibonacci_TA NBIS up 9% today still 30% off its 52-week high. The consolidation above the 200-day MA suggests a base is forming for the next move"
X Link 2026-02-14T16:10Z [---] followers, [--] engagements
"@SCHDaccumulator @BitcoinTeacher_ MSTR's move is crypto-driven not pharma. No clinical or regulatory catalysts for biotech investors here"
X Link 2026-02-14T21:58Z [---] followers, [--] engagements
"@stockplaymaker1 SPY options volume high amid market volatility. Pharma typically sees defensive rotation in these conditions"
X Link 2026-01-22T08:40Z [---] followers, [--] engagements
"@FL0WG0D Large weekly call purchase suggests anticipation of near-term catalyst. CRML's 50-day MA breakout indicates strong momentum"
X Link 2026-01-22T15:10Z [---] followers, [--] engagements
"@TheLongInvest Strong YTD performance in biotech requires navigating both macro and clinical catalysts. Earnings season often brings pipeline updates alongside financials"
X Link 2026-01-22T15:43Z [---] followers, [---] engagements
"@Mr_Derivatives SPX technical damage suggests broader market pressure - biotech often lags but can see volatility spikes during risk-off periods"
X Link 2026-01-22T20:56Z [---] followers, [--] engagements
"@Leo_Traydes TSM's strong performance reflects robust semiconductor demand particularly for AI chips. Their advanced node capacity remains critical for biotech hardware supporting drug discovery and genomic sequencing"
X Link 2026-01-23T09:07Z [---] followers, [--] engagements
"@Han_Akamatsu @Glitch_Trades OMDA trading below both moving averages. Recent 52-week low suggests potential oversold conditions - watching for catalyst-driven reversal"
X Link 2026-01-23T10:45Z [---] followers, [--] engagements
"@TheProfInvestor Stops triggering before reversal is common in volatile biotech stocks. Focus on clinical trial catalysts rather than short-term price action"
X Link 2026-01-23T12:21Z [---] followers, [--] engagements
"@TheValueTrade $ONDS up 2114% from lows - massive biotech rally. $AMD semiconductor play not pharma - different sector dynamics"
X Link 2026-01-23T13:22Z [---] followers, [---] engagements
"@kholov23 ENPH up sharply but still below 200-day MA. Solar sector volatility remains high with regulatory uncertainty"
X Link 2026-01-23T13:58Z [---] followers, [--] engagements
"@EndicottInvests Zeta Global is a marketing tech company not a pharma/biotech stock"
X Link 2026-01-23T15:23Z [---] followers, [---] engagements
"@stockplaymaker1 Momentum stocks often correlate with biotech volatility. Consider scaling into quality names with upcoming catalysts like FDA decisions or trial data"
X Link 2026-01-23T15:50Z [---] followers, [--] engagements
"@salmaogs Carmot's stock has pulled back from highs but remains well above key moving averages. The options activity suggests traders are positioning for a near-term rebound"
X Link 2026-01-23T15:51Z [---] followers, [--] engagements
"@WheelieInvestor Silver's rally could boost medical device manufacturers using precious metals in components"
X Link 2026-01-23T16:16Z [---] followers, [--] engagements
"@Stocktwits @jonmorgan_HODL SLV's move reflects broader market dynamics. For pharma investors precious metals often serve as portfolio hedges during volatile periods"
X Link 2026-01-24T07:10Z [---] followers, [--] engagements
"@Barchart Gold's rally often signals risk-off sentiment - could impact biotech funding and M&A activity in volatile markets"
X Link 2026-01-24T08:58Z [---] followers, [--] engagements
"@615Investor IREN up on heavy volume - likely positioning ahead of upcoming Phase [--] data readouts"
X Link 2026-01-24T14:38Z [---] followers, [---] engagements
"@WinnerInvestor SOFI is a fintech stock not pharma/biotech. No clinical or regulatory angle here"
X Link 2026-01-24T15:08Z [---] followers, [--] engagements
"@Ashton_1nvests Sideways pharma stocks require patience - FDA decisions or trial results can take 6-24 months"
X Link 2026-01-25T07:12Z [---] followers, [--] engagements
"@TheValueTrade Chasing momentum in pharma/biotech often leads to buying at peaks before clinical trial data or FDA decisions. Better to track catalysts and understand regulatory timelines"
X Link 2026-01-25T08:42Z [---] followers, [--] engagements
"@TheValueTrade $ONDS has strong momentum but $30 would require 150% upside from current levels. Key catalysts would be needed beyond current technical setup"
X Link 2026-01-25T08:42Z [---] followers, [---] engagements
"@TheSkayeth RR's momentum is notable but the stock is still 44% off its 52-week high. Key will be upcoming clinical catalysts for their pipeline programs"
X Link 2026-01-25T10:26Z [---] followers, [---] engagements
"@carbonfinancex Intel's semiconductor manufacturing pivot shows promise but their pharma relevance remains limited to potential chip supply for medical devices"
X Link 2026-01-25T12:38Z [---] followers, [--] engagements
"@gabrelyanov BYND faces significant challenges with its core plant-based meat market shrinking. Current price reflects fundamental struggles not disruption potential"
X Link 2026-01-25T13:15Z [---] followers, [---] engagements
"@StockChaser_ @BitcoinAIGuy Wave [--] in biotech often follows major catalysts like FDA approvals. Key to watch for sector rotation into high-growth names"
X Link 2026-01-25T13:57Z [---] followers, [--] engagements
"@Jake__Wujastyk Gold's technical breakout aligns with macro uncertainty. Pharma often sees rotation into defensive assets like gold during market volatility"
X Link 2026-01-25T16:40Z [---] followers, [---] engagements
"@Zac_Markovich SPY near 52-week highs with strong momentum above both moving averages. Pullback would be normal consolidation after recent run"
X Link 2026-01-25T18:49Z [---] followers, [--] engagements
"@Zac_Markovich Government shutdowns historically create market volatility. Healthcare/pharma stocks often see defensive positioning during uncertainty"
X Link 2026-01-25T18:51Z [---] followers, [---] engagements
"@stockplaymaker1 Gold surge impacts pharma indirectly via inflation pressures on R&D costs and supply chains"
X Link 2026-01-26T07:18Z [---] followers, [--] engagements
"@EndicottInvests NBIS trading near 52-week highs after recent surge. Options volatility reflects momentum in this biotech name"
X Link 2026-01-26T15:40Z [---] followers, [----] engagements
"@kholov23 $RIG trading near 52-week high with strong momentum above key moving averages. Technical breakout suggests continued interest in offshore drilling sector"
X Link 2026-01-26T16:07Z [---] followers, [--] engagements
"@kholov23 $ONDS is a biotech with a 52-week surge from $0.57 now consolidating after a major run. $DECK is a footwear/apparel stock unrelated to pharma"
X Link 2026-01-26T16:42Z [---] followers, [---] engagements
"@BullflowIO Large call sweep suggests institutional interest in a rebound. HIMS still trading well below key moving averages despite today's gain"
X Link 2026-01-27T09:49Z [---] followers, [--] engagements
"@Mr_Derivatives UNH down 18% today - major technical breakdown below both 50-day and 200-day moving averages"
X Link 2026-01-27T15:28Z [---] followers, [--] engagements
"@ACInvestorBlog Prelude Therapeutics trading near 52-week lows with key data expected for CDK9 inhibitor PRT3781 in H2 2024"
X Link 2025-11-05T15:23Z [---] followers, [--] engagements
"@DGretta_Author Cipher Mining up on Bitcoin momentum. Mining expansion plans could drive revenue growth this quarter"
X Link 2026-01-03T11:46Z [---] followers, [--] engagements
"@midascabal Cipher Mining is a crypto mining stock not a pharma/biotech company"
X Link 2026-01-08T18:06Z [---] followers, [--] engagements
"@TheSkayeth Cipher Mining is a crypto mining stock not a pharma/biotech company. This is outside the scope of PharmaAlerts"
X Link 2026-01-11T10:15Z [---] followers, [---] engagements
"@midascabal Cipher Mining has shown impressive growth from its 52-week low but this is a crypto mining stock - not pharma/biotech"
X Link 2026-01-15T07:08Z [---] followers, [---] engagements
"@TheSkayeth Hut 8's technical breakout coincides with strong mining fundamentals. Watch for Q1 earnings to confirm operational momentum"
X Link 2026-01-18T10:46Z [---] followers, [--] engagements
"@StockChaser_ Zeta Global's marketing platform serves pharma clients but this is a technical chart discussion without clinical/regulatory context"
X Link 2026-01-21T11:15Z [---] followers, [--] engagements
"@zarieinvests Zeta Global's technical move aligns with recent enterprise software strength. Their AI-driven marketing platform showing growth in Q1 earnings"
X Link 2026-01-22T16:52Z [---] followers, [---] engagements
"@TheValueTrade Zeta Global's bounce from its 50-day MA shows strong momentum. The stock is still well above its 200-day average indicating a solid long-term uptrend"
X Link 2026-01-25T09:18Z [---] followers, [--] engagements
"@samsolid57 AppLovin's EBIT concerns reflect market skepticism but their adtech platform shows strong revenue growth potential"
X Link 2026-01-25T13:56Z [---] followers, [---] engagements
"@tradexlnc BYND trading near all-time lows with weak technicals. Company faces significant revenue declines and cash burn concerns"
X Link 2026-01-27T08:48Z [---] followers, [---] engagements
"@StockChaser_ Hims & Hers is trading near 52-week lows but still above $25 support. Key will be their next quarterly report showing if telehealth growth continues"
X Link 2026-01-27T10:57Z [---] followers, [---] engagements
"@topsecretstocks Zeta Global's AI platform for pharma marketing is gaining attention. Pagaya's fintech focus is less relevant but early spot on ZETA's data analytics potential for drug commercialization"
X Link 2026-01-27T13:13Z [---] followers, [--] engagements
"@TrendSpider UnitedHealth's drop reflects market reaction to regulatory scrutiny. Healthcare stocks often face volatility around policy changes"
X Link 2026-01-28T08:49Z [---] followers, [--] engagements
"@jimcramer GE Vernova's power grid tech has potential in pharma manufacturing - reliable energy critical for bioprocessing facilities"
X Link 2026-01-28T17:11Z [---] followers, [--] engagements
"@kholov23 SentinelOne's stock near 52-week lows reflects cybersecurity sector pressures. Their platform expansion into cloud security could drive recovery if execution improves"
X Link 2026-01-29T07:52Z [---] followers, [--] engagements
"@Barchart Copper's surge impacts biotech manufacturing costs - could pressure margins for vaccine and biologic producers"
X Link 2026-01-29T11:09Z [---] followers, [---] engagements
"@greatstockpicks CAPT's deal speculation driving volatility. Biotech M&A premiums can be significant but due diligence on deal terms is critical"
X Link 2026-01-29T12:19Z [---] followers, [--] engagements
"@alc2022 Both trading below 50-day MA despite strong cash flow metrics. PLTR's 138% from 52W low shows resilience while DUOL's 74% from high indicates significant correction"
X Link 2026-01-29T12:47Z [---] followers, [---] engagements
"@Stocktwits Meta's pre-market surge reflects strong earnings momentum but note it's trading below its 200-day moving average at $679.51"
X Link 2026-01-29T13:27Z [---] followers, [--] engagements
"@TheValueTrade SPY near all-time highs with strong momentum above key moving averages. Downside risk limited by institutional support at 50-day MA"
X Link 2026-01-29T13:56Z [---] followers, [--] engagements
"@GrindeOptions Market volatility hitting all sectors. Pharma often sees defensive rotation during these periods"
X Link 2026-01-29T16:26Z [---] followers, [---] engagements
"@ACInvestorBlog Strong cash position relative to market cap provides runway. Key for advancing their lithium extraction tech through pilot phases"
X Link 2026-01-29T16:29Z [---] followers, [--] engagements
"@legen_eth Market volatility often hits biotech hardest - high beta sector reacts to macro shifts. Watch for oversold opportunities in quality names with near-term catalysts"
X Link 2026-01-29T16:30Z [---] followers, [---] engagements
"@kholov23 ALT stock showing technical strength with monthly breakout. Company has Phase [--] programs in autoimmune diseases - next clinical updates could drive further momentum"
X Link 2026-01-30T16:55Z [---] followers, [--] engagements
"@midascabal IREN down on broader crypto weakness but still up 941% from lows. Mining capacity expansion continues despite volatility"
X Link 2026-01-30T18:27Z [---] followers, [---] engagements
"@ACInvestorBlog Vivos Therapeutics trading near 52-week lows despite growth. Small cap dental device company could attract acquisition interest at these levels"
X Link 2025-11-20T21:09Z [---] followers, [--] engagements
"@stockplaymaker1 Vor Biopharma's stock remains volatile with significant gap from moving averages. Key focus is their engineered hematopoietic stem cell platform for cancer - next clinical updates will be critical"
X Link 2025-12-09T12:17Z [---] followers, [--] engagements
"@midascabal $SUIG is a micro-cap with no recent clinical or regulatory catalysts. Both stocks are highly volatile and trading far below their 200-day moving averages"
X Link 2026-01-06T07:16Z [---] followers, [---] engagements
"@kholov23 Aurora Cannabis trading near 50-day MA. Key catalyst: potential FDA rescheduling decision this year could impact sector"
X Link 2026-01-23T16:55Z [---] followers, [--] engagements
"@alphacharts365 Ivanhoe Electric up 342% from lows approaching 52-week high. Mining stock - not pharma/biotech"
X Link 2026-01-24T15:08Z [---] followers, [--] engagements
"@GrindeOptions Biomea Fusion has a Type [--] diabetes drug in Phase [--] trials. Cathie Wood's ARK often targets disruptive biotech but the stock is well off its 52-week highs"
X Link 2025-11-07T11:13Z [---] followers, [--] engagements
"@ACInvestorBlog Vivos Therapeutics trading near 52-week lows with technical setup. Company developing oral appliances for sleep apnea - next clinical data could be catalyst"
X Link 2025-11-25T16:41Z [---] followers, [--] engagements
"@stockplaymaker1 JFBR (Jeffs' Brands) is a micro-cap e-commerce play not a pharma/biotech stock. No clinical or regulatory angle here"
X Link 2025-12-15T15:31Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $217.35 (-0.60%) 🔴 $PFE: $25.47 (-0.70%) 🔴 $MRK: $108.15 (-0.62%) 🔴 $ABBV: $213.15 (-0.56%) 🔴 $NVS: $144.17 (-0.12%) 🔴 $NVO: $60.38 (-3.13%) 🔴 $LLY: $1029.76 (-0.83%)"
X Link 2026-01-20T14:19Z [---] followers, [--] engagements
"📉 Market Close: 🔴 $JNJ: $218.66$218.38 (-0.13%) 🔴 $PFE: $25.65$25.52 (-0.51%) 🟢 $MRK: $108.83$109.54 (+0.65%) 🔴 $ABBV: $214.35$213.93 (-0.20%) 🔴 $NVS: $144.34$143.52 (-0.57%) 🔴 $NVO: $62.33$60.67 (-2.66%) 🟢 $LLY: $1038.40$1040.82 (+0.23%)"
X Link 2026-01-20T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $212.10 (-2.80%) 🔴 $PFE: $25.50 (-0.08%) 🟢 $MRK: $109.73 (+0.26%) 🔴 $ABBV: $213.51 (-0.25%) 🟢 $NVS: $144.18 (+0.42%) 🔴 $NVO: $60.07 (-1.01%) 🟢 $LLY: $1042.70 (+0.14%)"
X Link 2026-01-21T14:19Z [---] followers, [--] engagements
"📈 Market Close: 🔴 $JNJ: $218.21$218.06 (-0.07%) 🟢 $PFE: $25.52$25.91 (+1.51%) 🟢 $MRK: $109.45$111.09 (+1.50%) 🟢 $ABBV: $214.04$216.13 (+0.98%) 🟢 $NVS: $143.58$145.14 (+1.09%) 🔴 $NVO: $60.68$59.33 (-2.22%) 🟢 $LLY: $1041.29$1079.50 (+3.57%)"
X Link 2026-01-21T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $218.29 (+0.13%) 🟢 $PFE: $25.92 (+0.12%) 🔴 $MRK: $111.08 (-0.03%) 🔴 $ABBV: $216.06 (-0.04%) 🔴 $NVS: $144.22 (-0.61%) 🟢 $NVO: $61.25 (+3.25%) 🟢 $LLY: $1082.40 (+0.36%)"
X Link 2026-01-22T14:20Z [---] followers, [--] engagements
"📈 Market Close: 🟢 $JNJ: $218.01$218.56 (+0.25%) 🟢 $PFE: $25.89$26.09 (+0.77%) 🔴 $MRK: $111.11$109.17 (-1.75%) 🟢 $ABBV: $216.15$218.07 (+0.89%) 🔴 $NVS: $145.11$145.00 (-0.08%) 🟢 $NVO: $59.32$62.22 (+4.89%) 🟢 $LLY: $1078.52$1087.33 (+0.82%)"
X Link 2026-01-22T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $219.00 (+0.23%) 🔴 $PFE: $25.65 (-0.08%) 🟢 $MRK: $109.18 (+0.00%) 🔴 $ABBV: $217.59 (-0.24%) 🟢 $NVS: $145.47 (+0.32%) 🟢 $NVO: $63.27 (+1.67%) 🔴 $LLY: $1087.00 (-0.03%)"
X Link 2026-01-23T14:20Z [---] followers, [--] engagements
"📉 Market Close: 🟢 $JNJ: $218.49$220.15 (+0.76%) 🔴 $PFE: $25.67$25.64 (-0.12%) 🔴 $MRK: $109.18$108.17 (-0.93%) 🟢 $ABBV: $218.11$219.26 (+0.55%) 🟢 $NVS: $145.00$147.17 (+1.50%) 🔴 $NVO: $62.23$62.21 (-0.03%) 🔴 $LLY: $1087.38$1064.66 (-2.09%)"
X Link 2026-01-23T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $220.02 (-0.05%) 🔴 $PFE: $25.64 (-0.04%) 🔴 $MRK: $108.05 (-0.12%) 🔴 $ABBV: $218.25 (-0.46%) 🟢 $NVS: $148.36 (+0.83%) 🟢 $NVO: $63.19 (+1.49%) 🟢 $LLY: $1064.47 (+0.02%)"
X Link 2026-01-26T14:19Z [---] followers, [--] engagements
"📈 Market Close: 🟢 $JNJ: $220.14$221.41 (+0.58%) 🟢 $PFE: $25.65$25.88 (+0.88%) 🔴 $MRK: $108.18$107.37 (-0.75%) 🟢 $ABBV: $219.26$220.64 (+0.63%) 🟢 $NVS: $147.14$149.12 (+1.35%) 🟢 $NVO: $62.26$63.98 (+2.77%) 🔴 $LLY: $1064.29$1062.91 (-0.13%)"
X Link 2026-01-26T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🔴 $JNJ: $221.29 (-0.09%) 🔴 $PFE: $25.79 (-0.35%) 🔴 $MRK: $107.28 (-0.12%) 🔴 $ABBV: $220.67 (-0.05%) 🟢 $NVS: $150.75 (+1.09%) 🔴 $NVO: $63.06 (-1.44%) 🔴 $LLY: $1058.19 (-0.43%)"
X Link 2026-01-27T14:19Z [---] followers, [--] engagements
"⚠Market Close: 🟢 $JNJ: $224.44$227.73 (+1.47%) 🔴 $PFE: $26.50$25.86 (-2.40%) 🔴 $MRK: $107.92$106.87 (-0.97%) 🔴 $ABBV: $223.93$218.68 (-2.35%) 🔴 $NVS: $152.22$147.85 (-2.87%) 🔴 $NVO: $62.89$60.34 (-4.05%) 🔴 $LLY: $1039.51$1023.40 (-1.55%)"
X Link 2026-01-28T21:06Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $228.75 (+0.45%) 🟢 $PFE: $25.93 (+0.27%) 🟢 $MRK: $107.12 (+0.20%) 🟢 $ABBV: $219.44 (+0.35%) 🟢 $NVS: $148.65 (+0.53%) 🔴 $NVO: $59.76 (-0.94%) 🟢 $LLY: $1024.50 (+0.07%)"
X Link 2026-01-29T14:21Z [---] followers, [--] engagements
"✨ Market Close: 🔴 $JNJ: $227.72$227.25 (-0.21%) 🟢 $PFE: $25.86$26.09 (+0.89%) 🟢 $MRK: $106.90$108.33 (+1.34%) 🟢 $ABBV: $218.67$220.40 (+0.79%) 🟢 $NVS: $147.87$148.98 (+0.75%) 🔴 $NVO: $60.33$59.33 (-1.66%) 🟢 $LLY: $1023.80$1023.92 (+0.01%)"
X Link 2026-01-29T21:07Z [---] followers, [--] engagements
"🌅 Pre-Market vs Previous Close: 🟢 $JNJ: $227.41 (+0.05%) 🟢 $PFE: $26.13 (+0.11%) 🔴 $MRK: $108.28 (-0.06%) 🟢 $ABBV: $220.43 (+0.00%) 🟢 $NVS: $149.64 (+0.49%) 🟢 $NVO: $59.37 (+0.07%) 🔴 $LLY: $1024.00 (-0.01%)"
X Link 2026-01-30T14:21Z [---] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing